Aptose to Report First Quarter 2023 Financial Results and Hold Conference Call on Monday, May 8, 2023 Apr 24, 2023 7:01am EDT
Aptose to Participate in Canaccord Genuity’s 2023 Horizons in Oncology Virtual Conference Apr 10, 2023 4:01pm EDT
Aptose Biosciences to Participate in Cantor’s The Future of Oncology Virtual Symposium Mar 28, 2023 4:01pm EDT
Aptose to Report Fourth Quarter and Full Year 2022 Financial Results and Hold Conference Call on Thursday, March 23, 2023 Mar 09, 2023 4:05pm EST
Aptose Biosciences to Present at Oppenheimer 33rd Annual Healthcare Conference Mar 02, 2023 7:30am EST
Aptose Initiates Dosing of Tuspetinib in APTIVATE Expansion Trial in Patients with Acute Myeloid Leukemia Jan 30, 2023 7:00am EST
